Davos BioSciences AG erreichte nach einigem Effort per 17.08.2021 das offizielle NORMA-Label der Swiss Biobanking Platform für deren Biobank Infrastruktur. Dies ist ein wichtiger Schritt für Davos BioSciences AG und CK-CARE.
Das NORMA-Label bestätigt: “Compliance with professional standards is essential to perform our daily biobanking activities according to Good Biobanking Practices; in particular OECD Best practice guidelines for biological resource centres (2007), ISBER Best practices (2018) and IARC Common minimum technical standards (2017). It follows established standards, including the ISO 20387:2018 – general requirements for biobanking. This certification approach is part of our long-term strategy to provide high-quality samples to the research community”.